|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2 USD | -33.33% |
|
-.--% | -66.67% |
| 2023 | Tengjun Biotechnology Corp. Announces Chief Executive Officer Changes | CI |
| 2023 | Tengjun Biotechnology Corp. Announces Chief Financial Officer Changes | CI |
Tengjun Biotechnology Corp. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 0.747525 million compared to USD 0.690886 million a year ago.
Basic loss per share from continuing operations was USD 0.04 compared to USD 0.04 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -66.67% | 201M | |
| +25.15% | 64.64B | |
| +35.00% | 34.08B | |
| +24.76% | 8.88B | |
| -0.62% | 6.71B | |
| +9.90% | 6.41B | |
| +1.77% | 5.05B | |
| +6.24% | 4.57B | |
| -10.25% | 3.23B | |
| +3.51% | 2.5B |
TENGJUN BIOTECHNOLOGY CORP. 
